Fact-checked by Grok 2 weeks ago

Acetophenone

Acetophenone is the with the chemical formula C₆H₅C(O)CH₃, representing the simplest aromatic where a is attached to the carbonyl carbon of an acetyl moiety. It appears as a colorless to pale yellow viscous liquid with a sweet, pungent, orange-blossom-like , possessing a molecular weight of 120.15 g/mol, a of 202.1 °C, a of 19.4 °C, and a of 1.028 g/cm³ at 20 °C. Slightly soluble in (approximately 6,130 mg/L at 25 °C), it is fully miscible with solvents and exhibits flammability with a of 77 °C. Primarily produced as a byproduct of cumene oxidation or through the Friedel-Crafts acylation of with using aluminum chloride as a catalyst, acetophenone serves as a versatile intermediate in . Its major applications include acting as a fragrance in perfumes, soaps, and detergents due to its ; a synthetic agent in foods, approved by the FDA; and a catalyst in the of olefins, as well as a and specialty for resins and plastics. In the pharmaceutical and chemical industries, it functions as a precursor for odorants, dyes, pharmaceuticals, and even riot control agents. Environmentally, acetophenone is moderately volatile and biodegradable in and , with atmospheric half-lives of about 6 days via reaction with hydroxyl radicals, though it poses risks as an irritant to eyes and and a potential at high concentrations. It occurs naturally in some , , and essential oils but is also detected in vehicle exhaust and emissions. Health assessments indicate low (oral LD50 in rats: 2.2 g/kg), with no evidence of carcinogenicity or mutagenicity, though exposure limits are set at 10 (TLV) to mitigate irritation and neurological effects.

Properties

Physical properties

Acetophenone has the molecular formula C₆H₅C(O)CH₃, corresponding to C₈H₈O, and a molecular weight of 120.15 g/mol. It appears as a colorless to pale yellow viscous liquid that solidifies into crystals at low temperatures, exhibiting a sweet, pungent reminiscent of orange blossoms. Key physical constants include a of 202.1 °C at 760 mmHg, a of 19.4 °C, a of 1.028 g/cm³ at 20 °C, and a of 1.5372 at 20 °C.
PropertyValueConditions
202.1 °C760 mmHg
19.4 °C-
1.028 g/cm³20 °C
1.537220 °C/D
Acetophenone is miscible with organic solvents such as , , acetone, , and , but has limited in at 0.613 g/100 mL (or 6.13 g/L) at 25 °C. Its is 0.397 mmHg at 25 °C, and the is 77 °C (closed cup).

Chemical properties

Acetophenone is the simplest aromatic , characterized by a ring directly attached to a , which is further bonded to a , giving the molecular formula C₈H₈O and systematic name 1-phenylethanone. The key is the carbonyl (C=O), which shows a characteristic stretching at approximately 1685 cm⁻¹, shifted lower due to conjugation with the aromatic ring. In ultraviolet-visible , it exhibits at around 242 (ε ≈ 12,000 in ), corresponding to the primary π-π* transition involving the . As a , acetophenone displays typical reactivity at the carbonyl carbon, undergoing reactions; for instance, it reacts with Grignard reagents such as methylmagnesium bromide to form a tertiary alcohol upon subsequent . The presence of α-hydrogens on the imparts acidity, facilitating enolization under basic conditions and enabling participation in reactions with other carbonyl compounds. Acetophenone is stable toward under neutral or mildly acidic conditions but is susceptible to oxidative cleavage by strong agents like (KMnO₄), which cleaves the C-C bond adjacent to the carbonyl, yielding as the primary product. Spectroscopic identification includes ¹H NMR signals with the methyl protons appearing as a singlet at δ 2.6 ppm and the aromatic protons as a multiplet between δ 7.5 and 8.0 ppm. In electron ionization mass spectrometry, the base peak occurs at m/z 105, corresponding to the benzoyl cation (C₆H₅CO⁺) formed by loss of the methyl radical from the molecular ion at m/z 120.

Synthesis

Industrial production

Acetophenone is primarily produced industrially as a of the oxidation process (Hock process) for phenol and acetone production, contributing over 90% to overall supply. In this process, acetophenone forms during the acid-catalyzed decomposition of . Alternative routes include the Friedel-Crafts acylation of with either or in the presence of aluminum chloride (AlCl3) as a Lewis acid catalyst. This reaction proceeds under conditions to prevent of the acylating agent, typically at temperatures between 40°C and 60°C, achieving high yields approaching 95%. The process is conducted in batch or continuous reactors, with careful control of the exothermic reaction to maintain selectivity and minimize polyacylation byproducts. Another industrial route involves the selective oxidation of using air or oxygen in the liquid phase, often catalyzed by or salts, to form acetophenone as the main product. This operates at moderate temperatures (around 100-130°C) and pressures, with acetophenone yields up to 85-90% based on optimized systems. Global production of acetophenone reached approximately 92,000 metric tons in 2024, with major manufacturing hubs in , the , and due to integrated complexes supplying downstream industries like resins and pharmaceuticals. The crude product from either route is purified via at reduced pressure (typically 10-50 mmHg) to separate acetophenone ( ~202°C at ) from unreacted , catalyst residues, and high-boiling impurities, achieving purities exceeding 99%. Historically, acetophenone production relied on coal tar-derived benzene before the 1950s, but shifted post-World War II to abundant petrochemical feedstocks like those from catalytic reforming and steam cracking, enabling scalable and cost-effective synthesis aligned with the growth of the global olefins and aromatics industry.

Laboratory preparation

Acetophenone is commonly prepared in the laboratory via the Friedel-Crafts acylation of benzene with acetic anhydride or acetyl chloride in the presence of a Lewis acid catalyst such as anhydrous aluminum chloride (AlCl₃). The reaction proceeds through electrophilic aromatic substitution, where the acylium ion (CH₃CO⁺) generated from the acylating agent attacks the benzene ring. In a typical procedure, benzene (approximately 0.02 mol) is mixed with AlCl₃ (0.075 mol) in a flask equipped with a reflux condenser and dropping funnel, followed by the dropwise addition of acetic anhydride (0.04 mol) over 30 minutes while controlling the exothermic reaction. The mixture is then refluxed for 1 hour, cooled, and quenched by pouring into a mixture of ice and concentrated HCl to hydrolyze the aluminum complex. The organic layer is extracted with diethyl ether, washed with NaOH solution to remove acidic impurities, dried over magnesium sulfate, and purified by vacuum distillation, yielding acetophenone in 70-85% isolated yield. Purity is assessed using thin-layer chromatography (TLC) with a suitable eluent like ethyl acetate/hexane or gas chromatography-mass spectrometry (GC-MS), showing a molecular ion at m/z 120. An alternative laboratory route involves the selective oxidation of styrene using a catalyst in a Wacker-type process, which converts the terminal to the methyl with high efficiency under mild conditions. For example, styrene is oxidized with or oxygen in the presence of PdCl₂ and a co-catalyst like CuCl₂ in an aqueous or medium at to 60°C, producing acetophenone in yields up to 88% after extraction and distillation. This method avoids harsh acids and is suitable for small-scale syntheses, with product via GC-MS confirming the . Another oxidation approach uses to convert to acetophenone by benzylic oxidation, though it requires careful control to prevent over-oxidation to ; is treated with CrO₃ in , followed by extraction and distillation, affording 50-70% yields. Modern variants enhance efficiency through techniques like microwave-assisted Friedel-Crafts acylation, where , , and AlCl₃ are irradiated at 100-150 W for 5-10 minutes, reducing reaction time from hours to minutes while maintaining 80-90% yields and minimizing side products. For substituted analogs, palladium-catalyzed couplings, such as the reaction of aryl halides with acetylzinc reagents or acyl stannanes, provide versatile access with yields of 70-95%, often under Suzuki-like conditions using Pd(PPh₃)₄ and a base. These methods emphasize purity and for applications. Safety considerations in preparations include handling AlCl₃ in a dry atmosphere to prevent violent reactions with , which generates HCl gas; reactions should be conducted in a with appropriate ventilation and acid-neutralizing traps. Oxidants like require disposal as due to .

Applications

Industrial and commercial uses

Acetophenone serves as a key ingredient in the fragrance industry, imparting a sweet, orange blossom-like odor that enhances floral compositions such as , , and accords in perfumes, soaps, detergents, creams, and lotions. In the flavor sector, it acts as a agent in foods, , and products, contributing almond- or cherry-like notes at low concentrations, typically up to 28 in categories like and ; it holds (GRAS) status from the FDA and FEMA for these applications. As a , acetophenone is utilized in the of plastics, resins, and inks due to its ability to dissolve , , vinyl resins, and resins, providing stability and a pleasant in formulations. Additionally, its derivatives, such as α-hydroxyacetophenones, serve as photoinitiators in UV-curing systems for inks, coatings, and adhesives, enabling rapid under light. As of 2024, the global acetophenone market was valued at approximately USD 215 million, projected to reach USD 249 million in 2025, with roughly 30% allocated to fragrances and flavors, 34% to solvents, and 35% to the , underscoring its commercial significance in these sectors. Historically, a of acetophenone, chloroacetophenone (known as ), was developed in the late and widely applied as a for starting in the early 20th century, including during and subsequent law enforcement uses.

Pharmaceutical and research uses

Acetophenone serves as a key intermediate in the synthesis of various pharmaceuticals, particularly through its conversion to derivatives via reduction, which are building blocks for antihistamines such as diphenhydramine analogs. It is also employed in the preparation of agents, including analogs of , where acetophenone derivatives undergo and steps to form the arylpropionic acid scaffold essential for non-steroidal anti-inflammatory drugs (NSAIDs). Additionally, acetophenone contributes to the synthesis of analgesics by providing the aromatic ketone moiety that can be functionalized into modulators or other pain-relief compounds. In research, acetophenone acts as a versatile reagent for constructing bioactive scaffolds, notably through the Claisen-Schmidt condensation with aldehydes to yield chalcones, which exhibit , , and anticancer properties and serve as precursors to flavones with similar therapeutic potential. It is frequently used as a model in asymmetric studies, particularly for the or of prochiral ketones to chiral alcohols, as demonstrated in Noyori-type ruthenium-catalyzed reactions that achieve high enantioselectivity for (R)-, a in many chiral pharmaceuticals. protocols often employ acetophenone as a standard compound for ketone reductions using (NaBH4) in methanolic solutions, yielding with near-quantitative efficiency, or for enamine formation with under acidic conditions to facilitate reactions in . Derivatives of acetophenone have garnered attention for their niche medicinal applications, including potential as antioxidants and antimicrobials; for instance, prenylated acetophenones isolated from demonstrate potent activity against and free radical scavenging comparable to ascorbic acid. Recent 2024 investigations into natural acetophenone analogs, such as paeonol and apocynin, highlight their cardioprotective effects through and vasodilatory mechanisms in ischemia-reperfusion models. For pharmaceutical applications, high-purity acetophenone is available in grades meeting (USP) standards to ensure compliance in drug manufacturing processes.

Natural occurrence

Sources in nature

Acetophenone occurs naturally in the essential oils of plants belonging to over 24 families, where it contributes to floral and fruity aromas. In tea plants (Camellia sinensis), it is a prominent volatile in flowers, comprising up to 31.1% of the essential oil extracted by simultaneous distillation-extraction, and is also present in leaves, imparting sweet, citrus-like notes derived from L-phenylalanine metabolism. Trace amounts appear in jasmine (Jasminum sambac) flowers, enhancing the characteristic scent during blooming, and in strawberry (Fragaria spp.) fruits as part of the volatile profile influencing aroma formation. In vetiver (Vetiveria zizanioides) roots, it constitutes approximately 1.08% of the essential oil. Fungal and microbial sources include strains of and , which produce acetophenone and its derivatives as secondary metabolites; for instance, freshwater isolates of Lindgomyces madisonensis yield acetophenone analogs under epigenetic modulation. Recent studies highlight its production by skin microbiota bacteria, enriched in flavivirus-infected mammalian hosts to modulate insect vector attraction. Trace levels of acetophenone are detected in mammalian urine, such as in red foxes (Vulpes vulpes), where it varies with metabolic factors and contributes to scent profiles (median 4.6 μg/mg ). In insects, it acts in chemical , including as an allelochemical influencing blood-feeding behavior. Isolation from these sources typically involves of materials or microbial cultures to obtain oils or extracts, followed by gas chromatography-mass (GC-MS) for and quantification; concentrations are generally below 1% in most oils but can reach higher in specific floral extracts. In nature, acetophenone serves evolutionary roles as a defense compound, deterring herbivores through emission after damage, or as a attractant in floral volatiles; it can also repel or draw depending on context, aiding plant-insect interactions.

Biosynthesis

In , acetophenone is primarily biosynthesized through the phenylpropanoid pathway, initiating from L- derived from the . L- is deaminated by the enzyme (PAL, EC 4.3.1.5) to form trans-, followed by side-chain shortening via a β-oxidative mechanism involving sequential β-hydroxylation, oxidation, and to yield acetophenone. This pathway has been elucidated in species such as , where feeding experiments with stable isotope-labeled precursors confirmed the incorporation of ¹³C from L-[ring-¹³C₆]phenylalanine into the aromatic ring of acetophenone, while ¹³C from [1-¹³C]cinnamic acid labeled both the carbonyl and methyl carbons, supporting the β-oxidative shortening of the . Labeling with sodium [1-¹³C] showed minimal incorporation into acetophenone, indicating that the acetyl moiety originates from the phenylpropanoid precursor rather than direct by . Hydroxyacetophenone derivatives, such as picein (4-hydroxyacetophenone β-D-glucoside) and pungenin, follow a similar initial route in conifers like (), where the acetophenone core is formed prior to in phase II metabolism. The UDP-glycosyltransferase (e.g., PgUGT5b) catalyzes the addition of glucose to the phenolic hydroxyl group, storing the compounds constitutively at levels up to 10% of needle dry mass in resistant genotypes. Upon stress, β-glucosidases like Pgβglu-1 hydrolyze these glucosides, releasing aglycones such as piceol and pungenol for . is upregulated by attack from spruce budworm (Choristoneura fumiferana), with resistant trees showing 1,000-fold higher β-glucosidase expression and up to 69% increases in aglycone levels post-feeding. In (), p-hydroxyacetophenone and picein accumulation is induced by abiotic stresses, including UV radiation and , serving as indicators of physiological strain with ratios shifting toward the aglycone under prolonged exposure. In fungi, acetophenone biosynthesis mirrors the β-oxidative pathway, starting from L-phenylalanine via PAL-mediated to , followed by side-chain degradation to the . This has been observed in the white-rot fungus Bjerkandera adusta, where the process contributes to , though specific downstream enzymes beyond PAL remain unidentified. Unlike polyketide routes in some fungal aromatic compounds, acetophenone formation here relies on phenylpropanoid-derived precursors rather than condensation. Microbial variants in bacteria often produce acetophenone as an intermediate in catabolic pathways rather than dedicated anabolic routes. In styrene-degrading bacteria such as Pseudomonas and Rhodococcus species, styrene is epoxidized by styrene monooxygenase (StyAB) to (S)-styrene oxide, which is isomerized by styrene oxide isomerase to 2-phenylethanol; subsequent oxidation by alcohol dehydrogenase and aldehyde dehydrogenase yields acetophenone en route to benzoic acid. This pathway enables transient accumulation of acetophenone during aerobic styrene catabolism. Additionally, commensal skin bacteria like Bacillus subtilis produce acetophenone as a volatile metabolite, with production enhanced by flavivirus infections (e.g., Zika or dengue), promoting mosquito attraction; however, the precise biosynthetic enzymes in these contexts are not fully characterized. Isotopic studies in bacterial systems are limited, but analogous labeling in related phenylpropanoid pathways confirms precursor origins from shikimate-derived aromatics. Regulation in bacteria may involve stress responses, such as quorum sensing or viral modulation of microbiota, but lacks the UV-specific induction seen in plants.

Biological effects

Pharmacology

Acetophenone and its derivatives exhibit various biological activities, including properties through radical scavenging mechanisms. For instance, certain natural acetophenone derivatives, such as those isolated from ebracteolata and , demonstrate potent effects in the assay, with values of approximately 34.62 μg/mL and 20.02 μM, respectively, indicating their ability to neutralize free radicals by donating hydrogen atoms or electrons. effects have been observed in derivatives like acetophenone , which reduce pain responses in acetic acid-induced writhing tests in mice by inhibiting (COX) pathways, thereby decreasing prostaglandin-mediated and . Pharmacokinetic profiles of acetophenone derivatives, such as paeonol (2'-hydroxy-4'-methoxyacetophenone), reveal rapid absorption following , with good estimated around 70% in some formulations, though overall low due to poor aqueous . Metabolism primarily occurs via enzymes, including , leading to oxidation products like derivatives, while the elimination is short, typically 2-4 hours, facilitating quick clearance but limiting sustained exposure. Therapeutic potential of acetophenone derivatives includes applications in drugs, exemplified by analogs related to bupivacaine, which modulate and reduce through COX inhibition. A 2024 review highlights the cardioprotective role of paeonol via activation of the Nrf2/HO-1 pathway, which upregulates antioxidant enzymes like and , mitigating and improving cardiac remodeling in models. At the molecular level, the ketone in acetophenone facilitates hydrogen bonding interactions with biological receptors, such as those involved in active sites or signaling pathways, enhancing binding affinity and bioactivity. Chiral analogs display enantioselective effects, where specific stereoisomers exhibit differential potency in biological assays, such as in the reduction of prochiral ketones to alcohols with varying enantiomeric excess. Clinical data on acetophenone itself remains limited, with no large-scale trials reported; however, preclinical studies demonstrate efficacy in models, including a 40% reduction in writhing responses in acetic acid-induced assays for derivatives like α-(phenylselanyl) acetophenone, supporting their potential as agents.

Toxicity

Acetophenone exhibits moderate acute toxicity via oral administration, with an LD50 of 2081 mg/kg in rats according to OECD Test Guideline 401. Inhalation exposure shows low acute toxicity, with an LC50 greater than 210 ppm over 8 hours in rats and 1200 mg/m³ (244 ppm) over 4 hours in mice. The compound acts as a mild skin irritant in rabbits based on Draize testing, potentially causing dryness or cracking upon prolonged contact, while it produces severe eye irritation, including corneal injury in rabbits and transient effects in humans. Chronic exposure data for acetophenone in humans are limited, with no established evidence of carcinogenicity (classified as Group D by the EPA). As a , repeated may pose risks of neurotoxic effects such as , prompting the OSHA (PEL) of 10 ppm as an 8-hour time-weighted average to mitigate and symptoms. Earlier (as of 2015 EPA assessment) indicated no reproductive or developmental at doses up to 750 mg/kg/day over 28 days in rats, with no fetal abnormalities observed; however, a 2025 ECHA RAC opinion proposes classifying acetophenone as a reproductive Category 1B (H360FD: may damage and the unborn child) based on evidence of developmental in rat studies, pending final regulatory adoption. Under EU REACH regulations, acetophenone's harmonised classification (as of November ) is Category 4 (oral; H302: Harmful if swallowed) and Eye Irritation Category 2 (H319: Causes serious eye irritation). A 2025 RAC opinion proposes adding Category 1B (H360FD) and Specific Target Organ Toxicity (single exposure) Category 3 (H336: May cause drowsiness or ). The 2025 OSHA standards reaffirm the PEL of 10 to address potential solvent-related hazards. In the environment, acetophenone is biodegradable, with reported half-lives of 4.5 days in lake water, 8 days in river water, and 32 days in under aerobic conditions. It demonstrates low bioaccumulation potential, with a bioconcentration factor (BCF) of approximately 1 and a log Kow of 1.63, indicating minimal partitioning into fatty tissues or adsorption (Koc 10-270). To mitigate exposure risks, such as gloves, goggles, and respiratory protection should be used, alongside adequate in handling areas. In case of , immediate flushing with water for at least 15 minutes is recommended, followed by medical attention; skin contact requires washing with soap and water. Given the proposed classification, additional precautions may be advised for pregnant workers or in consumer product formulations pending final EU decisions.